Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation [...]
Tetragenetics is a Massachusetts-based drug discovery platform that offers solutions such as protein production and antibody discovery for the pharmaceutical sector.